期刊文献+

他克莫司治疗原发性肾病综合征的临床分析 被引量:3

The clinical analyzing of treatment primary nephrotic syndrome by tacrolimus
下载PDF
导出
摘要 目的 探讨他克莫司治疗原发性肾病综合征的临床疗效情况。方法 选取2011年2月-2015年3月我院肾内科收治原发性肾病综合征患者30例临床资料,依据治疗措施不同进行分组,对照组(环磷酰胺联合醋酸泼尼松治疗)15例和他克莫司组(他克莫司联合醋酸泼尼松治疗)15例。比较两组原发性肾病综合征患者治疗前和治疗6个月后血清白蛋白、肌酐、胆固醇、三酰甘油、尿蛋白定量情况以及两组患者临床疗效情况。结果 两组原发性肾病综合征患者治疗前血清白蛋白、肌酐、胆固醇、三酰甘油、尿蛋白定量比较,差异无统计学意义(P〉0.05),对照组和他克莫司组治疗6个月后血清白蛋白均高于治疗前,肌酐、胆固醇、三酰甘油、尿蛋白定量均低于治疗前,他克莫司组治疗6个月后血清白蛋白均高于对照组,肌酐、胆固醇、三酰甘油、尿蛋白定量均低于对照组,他克莫司组原发性肾病综合征患者治疗缓解率高于对照组,差异有统计学意义(χ^2=7.65,P〈0.05)。结论 他克莫司治疗原发性肾病综合征患者临床症状改善明显,缓解率高,值得临床推广应用。 Objective To explore the clinical effects of treatment primary nephrotic syndrome by tacrolimus.Methods 30 cases clinical data of primary nephrotic syndrome patients in our hospital department of nephrology from February 2011 to March 2015 were selected,and divided into two groups by different treatment methods,the control group (cytoxan compared with prednisone acetate treatment)15 cases and the Tacrolimus group (prednisone acetate compared with tacrolimus treatment)15 cases.The serum albumin,creatinine,cholesterol,triglyceride,urine protein quantitation of two groups primary nephrotic syndrome patients before treatment and after treatment 6 moths were compared,clinical curative effect of two groups primary nephrotic syndrome patients were compared.Results The serum albumin,creatinine, eholesterol,triglyceride,urine protein quantitation of two groups primary nephrotic syndrome patients before treatment were no significant differenee(P〉0.05),the serum albumin of control group and Tacrolimus group after treatment 6 moths were higher than before treatment;the creatinine,cholesterol,triglyceride,urine protein quantitation were lower than before treatment;the serum albumin of Tacrolimus group after treatment 6 moths was higher than that of control group;the creatinine,cholesterol,triglyceride,urine protein quantitation were lower than that of control group;the remission rate of treatment group was higher than that of control group,the differences were significant(χ^2=7.65,P〈0.05).Conclusion The clinical symptoms of treatment primary nephrotic syndrome by tacrolimus is obviously,remission rate is high,it is worth to be used.
出处 《中国当代医药》 2016年第35期129-131,共3页 China Modern Medicine
关键词 他克莫司 原发性肾病综合征 白蛋白 肌酐 尿蛋白定量 Tacrolimus Primary nephrotic syndrome Albumin Creatinine Urine protein quantitation
  • 相关文献

参考文献8

二级参考文献65

  • 1纪松岗,徐霞,王春燕,梁东升,许自明.3例肾移植患者口服大黄制剂后引起环孢素全血谷浓度增高[J].中国药师,2005,8(1):48-49. 被引量:15
  • 2Christina DL,Varvara A,Andromachi M,et al.Safety,immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome[J].Vaccine,2011,29(40):6834-6837.
  • 3Rachel L,Louise W,Nicholas JAW.Nephrotic syndrome in children[J].Paediatrics and Child Health,2010,20(1):36-42.
  • 4Lawrence C,Orng SO,Sarah T,et al.Childhood nephrotic syndrome in Cambodia:an association with gastrointestinal parasites[J].The Journal of Pediatrics,2010,156(1):76-81.
  • 5Swati C,Arvind B,Pankaj H,et al.Efficacy and safety of Tacrolimus versus Cyclosporine in children with steroid-resistant nephrotic syndrome:a randomized controlled trial[J].American Journal of Kidney Diseases,2009,53(5):760-769.
  • 6Nikoleta P,Fotios P,Vassiliki T,et al.IL-18 is correlated with type-2 immune response in children with steroid sensitive nephrotic syndrome[J].Cytokine,2008,44(2):262-268.
  • 7Kusunoki Y, Tanaka N, Kaneko K, et al. Taerolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study [J]. Mod Rheumatol, 2009,19 (6) :616-621.
  • 8Lee Y H, Woo J H, Choi S J, et al. Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials [J]. Scand J Rheumatol, 2010,39(4) :271-278.
  • 9Li X, Li H, Ye H, et al. Tacrolimus therapy in adults with steroid-and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR [J]. Am J Kidney Dis, 2009, 54(1) :51-58.
  • 10Chen W, Liu Q, Liao Y, et al. Outcomes of tacrolimus therapy in adults with refractory membranous nephmtic syndrome: a prospective, multieenter clinical trial [J]. Am J Med Sci, 2013,345 (2) :81-87.

共引文献169

同被引文献17

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部